+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amicus Therapeutics Inc - logo
Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030 - Product Thumbnail Image

Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030

  • Report
  • July 2020
  • 283 Pages
  • Global
From
Global Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase Beta, Migalastat, Pipeline Drugs), Route of Administration - Forecast 2024-2030 - Product Thumbnail Image

Global Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase Beta, Migalastat, Pipeline Drugs), Route of Administration - Forecast 2024-2030

  • Report
  • March 2024
  • 184 Pages
  • Global
From
Global Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Forecast 2024-2030 - Product Thumbnail Image

Global Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Forecast 2024-2030

  • Report
  • March 2024
  • 181 Pages
  • Global
From
Global Fabry Disease Drugs Market 2024-2028 - Product Thumbnail Image

Global Fabry Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 149 Pages
  • Global
From
Global Pompe Disease Drugs Market 2024-2028 - Product Thumbnail Image

Global Pompe Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Batten Disease (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Batten Disease (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 103 Pages
  • Global
From
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 218 Pages
  • Global
From
Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • September 2023
  • 119 Pages
  • Global
From
Alpha Galactosidase A Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Alpha Galactosidase A Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 105 Pages
  • Global
From
Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 94 Pages
  • Global
From
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 105 Pages
  • Global
From
Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 102 Pages
  • Global
From
Lysosomal Storage Diseases - Global Strategic Business Report - Product Thumbnail Image

Lysosomal Storage Diseases - Global Strategic Business Report

  • Report
  • May 2024
  • 193 Pages
  • Global
From
Global Fibromyalgia Therapeutics Market by Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2024-2030 - Product Thumbnail Image

Global Fibromyalgia Therapeutics Market by Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2024-2030

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Global Dilated Cardiomyopathy Therapeutics Market by Drug class, Treatment Type, Route of Administration, End-User, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Dilated Cardiomyopathy Therapeutics Market by Drug class, Treatment Type, Route of Administration, End-User, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 192 Pages
  • Global
From
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities - Product Thumbnail Image

Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities

  • Report
  • June 2020
  • 100 Pages
  • China
From
Global Gaucher Disease Treatment Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3), Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy), Diagnosis, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Gaucher Disease Treatment Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3), Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy), Diagnosis, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Global Metabolic Disorders Therapeutics Market by Disease Type (Diabetes, Hypercholesterolemia, Lysosomal Storage Disease), Product (Globoid Leukodystrophy, Hepatic Encephalopathy, Metachromatic Leukodystrophy) - Forecast 2024-2030 - Product Thumbnail Image

Global Metabolic Disorders Therapeutics Market by Disease Type (Diabetes, Hypercholesterolemia, Lysosomal Storage Disease), Product (Globoid Leukodystrophy, Hepatic Encephalopathy, Metachromatic Leukodystrophy) - Forecast 2024-2030

  • Report
  • March 2024
  • 199 Pages
  • Global
From
Global Neurometabolic Disorders Market by Disease Type, by Route of Administration, by End-User, and By Region - Product Thumbnail Image

Global Neurometabolic Disorders Market by Disease Type, by Route of Administration, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Loading Indicator